Exicure, Inc. Files 8-K for Other Events
Ticker: XCUR · Form: 8-K · Filed: Aug 15, 2024 · CIK: 1698530
| Field | Detail |
|---|---|
| Company | Exicure, Inc. (XCUR) |
| Form Type | 8-K |
| Filed Date | Aug 15, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
TL;DR
EXICURE files 8-K for other events and financials. Stay tuned.
AI Summary
Exicure, Inc. filed an 8-K on August 15, 2024, to report other events and financial statements. The company, formerly known as Max-1 Acquisition Corp, is incorporated in Delaware and operates in the pharmaceutical preparations sector. The filing details its principal executive offices located at 2430 N. Halsted St., Chicago, IL.
Why It Matters
This filing provides an update on Exicure, Inc.'s corporate activities and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks or material adverse information.
Key Players & Entities
- EXICURE, INC. (company) — Registrant
- Max-1 Acquisition Corp (company) — Former company name
- 2430 N. Halsted St. (location) — Principal executive offices address
- Chicago, IL (location) — Principal executive offices city and state
- August 15, 2024 (date) — Date of earliest event reported
FAQ
What is the primary business of Exicure, Inc.?
Exicure, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on August 15, 2024.
What was Exicure, Inc.'s former name?
Exicure, Inc.'s former name was Max-1 Acquisition Corp.
Where are Exicure, Inc.'s principal executive offices located?
Exicure, Inc.'s principal executive offices are located at 2430 N. Halsted St., Chicago, IL 60614.
What is the fiscal year end for Exicure, Inc.?
Exicure, Inc.'s fiscal year ends on December 31st.
Filing Stats: 686 words · 3 min read · ~2 pages · Grade level 10.3 · Accepted 2024-08-15 10:42:45
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share XCUR The Nasdaq Stock Market
Filing Documents
- xcur-20240815.htm (8-K) — 27KB
- a8k81524exhibit991.htm (EX-99.1) — 7KB
- exicureimage1a10.gif (GRAPHIC) — 3KB
- 0001698530-24-000091.txt ( ) — 161KB
- xcur-20240815.xsd (EX-101.SCH) — 2KB
- xcur-20240815_lab.xml (EX-101.LAB) — 21KB
- xcur-20240815_pre.xml (EX-101.PRE) — 12KB
- xcur-20240815_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events. Exicure, Inc. (Nasdaq: XCUR, the "Company") announced today that its Special Meeting of Stockholders (the "Special Meeting") scheduled for and convened on August 15, 2024 has been adjourned for the purpose of soliciting additional votes with respect to the proposal described in the Company's definitive proxy statement for the Special Meeting filed with the Securities and Exchange Commission (the "SEC") on July 30, 2024. The presence, in person, by remote communication or by proxy, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum. There was less than the required majority represented at the Special Meeting, so a quorum did not exist. At the time the Special Meeting was adjourned, proxies had been submitted by stockholders representing approximately 49.4% of the outstanding shares of stock entitled to vote. The Special Meeting will be reconvened on August 19, 2024 at 9:00 a.m. Central Time and will continue to be held virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.com/XCUR2024SM. The record date for determination of stockholders entitled to vote at the reconvened Special Meeting remains July 26, 2024. Proxies previously submitted in respect of the Special Meeting will be voted at the adjourned Special Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action. Stockholders who have not yet voted are encouraged to vote as soon as possible via the Internet at www.proxyvote.com or by phone at 1-800-690-6903. You will be asked to provide the control number from your proxy card and follow the instructions. If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received these proxy materials and a voting instructions from that organization rather than from us. Simply follow the instructions to ensure that y
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press release dated August 15, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2024 EXICURE, INC. By: /s/ Paul Kang Paul Kang Chief Executive Officer